The Kell blood group system: Kell and XK membrane proteins

Seminars in Hematology

Volumn 37, Issue 2, 2000, Pages 113-121

  Lee, Soohee ^a,b   Russo, David ^a   Redman, Colvin M ^a  

^a NEW YORK BLOOD CENTER   (United States)

^b Lindsley F Kimball Res Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIN 3; MEMBRANE PROTEIN; PROTEIN KELL; PROTEIN XK; UNCLASSIFIED DRUG;

ANEMIA; ARTICLE; BLOOD GROUP KELL SYSTEM; BLOOD TRANSFUSION; ERYTHROPOIESIS; IMMUNOGENICITY; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SENSITIZATION; TISSUE DISTRIBUTION;

EID: 0034081001     PISSN: 00371963     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0037-1963(00)90036-2     Document Type: Article

References (62)

1. Avent ND, Martin PG: Kell typing by allele-specific PCR (ASP). Br J Haematol 93:728-730, 1996
2. Baynash AG, Hosoda K, Giaid A, et al: Interaction of endothelin-3 with endothelin-B receptor is essential for development of epidermal melanocytes and enteric neurons. Cell 79:1277-1285, 1994
3. Bertelson CJ, Pogo AO, Chaudhuri A, et al: Localization of the McLeod locus (XK) within Xp21 by deletion analysis. Am J Hum Genet 42:703-711, 1988
4. Bowman JM, Pollock JM, Manning FA, et al: Maternal Kell blood group alloimmunization. Obstet Gynecol 79:239-244, 1992
5. Caine ME, Mueller-Heubach E: Kell sensitization in pregnancy. Am J Obstet Gynecol 154:85-90, 1986
6. Carbonnet F, Hattab C, Cartron JP, et al: Kell and Kx, two disulfide-linked proteins of the human erythrocyte membrane are phosphorylated in vivo. Biochem Biophys Res Commun 247:569-575, 1998
7. Carbonnet F, Hattab C, Collec E, et al: Immunochemical analysis of the Kx protein from human red cells of different Kell phenotypes using antibodies raised against synthetic peptides. Br J Haematol 96:857-863, 1997
8. Clouthier DE, Hosoda K, Richardson JA, et al: Cranial and cardiac neural crest defects in endothelin-A receptor-deficient mice. Development 125:813-824, 1998
9. Daniels GL, Weinauer F, Stone C, et al: A combination of the effects of rare genotypes at the XK ana KEL blood group loci results in absence of Kell system antigens from the red blood cells. Blood 88:4045-4050, 1996
10. Du L, Desbarats M, Viel J, et al: cDNA cloning of the Murine Pex gene implicated in X-linked hypophosphatemia and evidence for expression in bone. Genomics 36:22-28, 1998
11. Emoto N, Yanagisawa M: Endothelin-converting enzyme-2 is a membrane-bound, phosphoramidon-sensitive metalloprotease with acidic pH optimum. J Biol Chem 270:15262-15268, 1995
12. Hessner MJ, McFarland JG, Endean DJ: Genotyping of KEL1 and KEL2 of the human Kell blood group system by the polymerase chain reaction with sequence-specific primers. Transfusion 36:495-499, 1996
13. Ho M, Chelly J, Carter N, et al: Isolation of the gene for McLeod syndrome that encodes a novel membrane transport protein. Cell 77:869-880, 1994
14. Ho MF, Monaco AP, Blonden LA, et al: Fine mapping of the McLeod locus (XK) to a 150-380-kb region in Xp21. Am J Hum Genet 50:317-330, 1992
15. Hoang MV, Turner AJ: Novel activity of endothelinconverting enzyme: Hydrolysis of bradykinin. Biochem J 327:23-26, 1997
16. Hosoda K, Hammer RE, Richardson JA, et al: Targeted and natural (piebald-lethal) mutations of endothelin-B receptor gene produce megacolon associated with spotted coat color in mice. Cell 79:1267-1276, 1994
17. Kenny AJ, O'Hare MJ, Gusterson BA: Cell-surface peptidases as modulators of growth and differentiation. Lancet 2:785-787, 1989
18. Khamlichi S, Bailly P, Blanchard D, et al: Purification and partial characterization of the erythrocyte Kx protein deficient in McLeod patients. Eur J Biochem 228:931-934, 1995
19. Kurihara Y, Kurihara H, Oda H, et al: Aortic arch malformations and ventricular septal defect in mice deficient in endothelin-1. J Clin Invest 96:293-300, 1995
20. Kurihara Y, Kurihara H, Suzuki H, et al: Elevated blood pressure and craniofacial abnormalities in mice deficient in endothelin-1. Nature 368:703-710, 1994
21. Lee S, Naime D, Reid ME, et al: Molecular basis for the high-incidence antigens of the Kell blood group system. Transfusion 37:1117-1122, 1997
22. Lee S: Molecular basis of Kell blood group phenotypes. Vox Sang 73:1-11, 1997
23. Lee S, Lin M, Mele A, et al: Proteolytic processing of big endothelin-3 by the Kell blood group protein. Blood 94:1440-1450, 1999
24. Lee S, Naime D, Reid M, et al: The KEL24 and KEL14 alleles of the KeM blood group system. Transfusion 37:1035-1038, 1997
25. Lee S, Wu X, Reid M, et al: Molecular basis of the K:6,-7 [Js(a+b-)] phenotype in the Kell blood group system. Transfusion 35:822-825, 1995
26. Lee S, Wu X, Reid M, et al: Molecular basis of the Kell (K1) phenotype. Blood 85:912-916, 1995
27. Lee S, Wu X, Son S, et al: Point mutations characterize KEL10, the KEL3, KEL4, and KEL21 alleles, and the KEL17 and KEL11 alleles. Transfusion 36:490-494, 1996
28. Lee S, Zambas E, Green ED, et al: Organization of the gene encoding the human Kell blood group protein. Blood 85:1364-1370, 1995
29. Lee S, Zambas ED, Marsh WL, et al: Molecular cloning and primary structure of Kell blood group protein. Proc Natl Acad Sci USA 88:6353-6357, 1991
30. Lee S, Zambas ED, Marsh WL, et al: The human Kell blood group gene maps to chromosome 7q33 and its expression is restricted to erythroid cells. Blood 81:2804-2809, 1993
31. Lee SH, Bennett PR, Overton T, et al: Prenatal diagnosis of Kell blood group genotypes: KEL1 and KEL2. Am J Obstet Gynecol 175:455-459, 1996
32. Leggat HM, Gibson JM, Barron SL, et al: Anti-Kell in pregnancy. Br J Obstet Gynaecol 98:162-165, 1991
33. Lipman ML, Panda D, Bennett HPJ, et al: Cloning of human PEX cDNA - Expression, subcellular localization, and endopeptidase activity. J Biol Chem 273:13729-13737, 1998
34. Lu B, Fikrig SM, Emanueli C, et al: The control of microvascular permeability and blood pressure by neutral endopeptidase. Nat Med 8:904-907, 1997
35. Lu B, Gerard NP, Kolakowski LF Jr, et al: Neutral endopeptidase modulation of septic shock. J Exp Med 181:2271-2275, 1995
36. Marsh WL, Redman CM: Recent developments in the Kell blood group system. Transfus Med Rev 1:4-20, 1987
37. Marsh WL, Redman CM: The Kell blood group system: A review. Transfusion 30:158-167, 1990
38. Masaki T: Possible role of endothelin in endothelial regulation of vascular tone. Ann Rev Pharmacol Toxicol 35:235-255, 1995
39. Mifsud NA, Haddad AP, Sparrow RL, et al: Use of polymerase chain reaction-sequence specific oligonucleotide technique for the detection of the K1/K2 polymorphism of the Kell blood group system. Blood 89:4662-4663, 1997
40. Puffenberger EG, Hosoda K, Washington SS, et al: A missense mutation of the endothelin-B receptor gene in multigenic Hirschsprung's disease. Cell 79:1257-1266, 1994
41. Redman CM, Avellino G, Pfeffer SR, et al: Kell blood group antigens are part of a 93,000-dalton red cell membrane protein. J Biol Chem 261:9521-9525, 1986
42. Redman CM, Marsh WL: The Kell blood group system and the McLeod phenotype. Semin Hematol 30:209-218, 1993
43. Roques BP, Noble F, Dauge V, et al: Neutral endopeptidase 24.11: Structure, inhibition, and experimental and clinical pharmacology. Pharmacol Rev 45:87-146, 1993
44. Rowe PS, Oudet CL, Francis F, et al: Distribution of mutations in the PEX gene in families with X-linked hypophosphataemic rickets (HYP). Hum Mol Genet 6:539-549, 1997
45. Russo D, Redman C, Lee S: Association of XK and Kell blood group proteins. J Biol Chem 273:13950-13956, 1998
46. Russo DC, Lee S, Reid M, et al: Topology of Kell blood group protein and the expression of multiple antigens by transfected cells. Blood 84:3518-3523, 1994
47. 412 with a similar catalytic mechanism and a distinct substrate binding mechanism compared with neutral endopeptidase-24.11. Biochem J 315:863-867, 1996
48. Shipp MA, Look AT: Hematopoietic differentiation antigens that are membrane-associated enzymes: Cutting is the key. Blood 82:1052-1070, 1993
49. Shipp MA, Stefano GB, Switzer SN, et al: CD10 (CALLA)/neutral endopeptidase 24.11 modulates inflammatory peptide-induced changes in neutrophil morphology, migration, and adhesion proteins and is itself regulated by neutrophil activation. Blood 78:1834-1841, 1991
50. Shipp MA, Tarr GE, Chen CY, et al: CD 10/neutral endopeptidase 24.11 hydrolyzes bombesin-like peptides and regulates the growth of small cell carcinomas of the lung. Proc Natl Acad Sci USA 88:10662-10666, 1991
51. Spence WC, Maddalena A, Demers DB, et al: Prenatal determination of genotypes Kell and Cellano in at-risk pregnancies. J Reprod Med 42:353-357, 1997
52. Stjernquist M: Endothelins - Vasoactive peptides and growth factors. Cell Tissue Res 292:1-9, 1998
53. Turner AJ, Murphy LJ: Molecular pharmacology of endothelin converting enzymes. Biochem Pharmacol 51:91-102, 1996
54. Turner AJ, Murphy LJ, Medeiros MS, et al: Endopeptidase-24.11 (neprilysin) and relatives. Twenty years on, in Suzuki K, Bond J (eds): Intracellular Protein Catabolism. New York, NY, Plenum, 1996, pp 141-148
55. Turner AJ, Tanzawa K: Mammalian membrane metallopeptidases: NEP ECE, KELL, and PEX. FASEB J 11:355-364, 1997
56. Valdenaire O, Richards JG, Faull RL, et al: XCE, a new member of the endothelin-converting enzyme and neutral endopeptidase family, is preferentially expressed in the CNS. Mol Brain Res 64:211-221, 1999
57. Vaughan JI, Manning M, Warwick RM, et al: Inhibition of erythroid progenitor cells by anti-Kell antibodies in fetal alloimmune anemia. N Engl J Med 338:798-803, 1998
58. Vaughan JI, Warwick R, Letsky E, et al: Erythropoietic suppression in fetal anemia because of Kell alloimmunization. Am J Obstet Gynecol 171:247-252, 1994
59. Weiner CP, Widness JA: Decreased fetal erythropoiesis and hemolysis in Kell hemolytic anemia. Am J Obstet Gynecol 174:547-551, 1996
60. Xu D, Emoto N, Giaid A, et al: ECE-1: A membrane-bound metalloprotease that catalyzes the proteolytic activation of big endothelin-1. Cell 78:473-485, 1994
61. Yanagisawa H, Yanagisawa M, Kapur RP, et al: Dual genetic pathways of endothelin-mediated intercellular signaling revealed by targeted disruption of endothelin converting enzyme-1 gene. Development 125:825-836, 1998
62. Yazdanbakhsh K, Lee S, Yu Q, et al: Identification of a defect in the intracellular trafficking of a Kell blood group variant. Blood 94:310-318, 1999